Resultados da pesquisa - ((drug (dosev OR dosen)) OR (drug dose)) devel ther*

Pesquisas alternativas:
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa), develop them (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)

21

Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?

Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus...

Por Qian, Yan-Ying, Dai, Zhi-Juan, Ruan, Lu-Ya, Pan, You-Jin, Jin, Jian, Shi, Meng-Te, Zhu, Yao-Xin, Wu, Chao-Ming
Publicado no Drug Des Devel Ther (2019)

“... of developing low-dose ADV-induced nephrotoxicity; therefore, it was worth paying attention to the side effects...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

22

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia

Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia

Por Dimitropoulos, Konstantinos, Gravas, Stavros
Publicado no Drug Des Devel Ther (2015)

“.... Therefore, it is well understood that LUTS have multifactorial etiology and often occur in clusters...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

23

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Por Hayes, Jennifer, Anderson, Rosie, Stephens, Jeffrey W
Publicado no Drug Des Devel Ther (2016)

“... is a therapy for type 2 diabetes and is available as a fixed-dose combination with metformin. Phase III...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

24

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO(®) (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination...

Por Choi, YoonJung, Han, HyeKyung, Shin, Dongseong, Lim, Kyoung Soo, Yu, Kyung-Sang
Publicado no Drug Des Devel Ther (2015)

“... and esomeprazole after a single oral dose. Both drugs were well-tolerated without any safety issues....”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

25

Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin in healthy Korean volunteers: a randomized, open, single-dose, parallel study

Dose-proportional pharmacokinetic properties of GLA5PR GLARS-NF1 controlled-release pregabalin...

Por Shin, Kwang-Hee, Jeon, Ji-Young, Jang, Kyungho, Kim, Tae-Eun, Kim, Min-Gul
Publicado no Drug Des Devel Ther (2018)

“...PURPOSE: The aim of this study was to evaluate the dose-proportional pharmacokinetic...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

26

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date

Por Vilela-Martin, José Fernando
Publicado no Drug Des Devel Ther (2016)

“... a therapeutic target for several drugs tested in cardiovascular disease, mainly for heart failure...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

27

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials

Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials

Por Xu, Na, Chen, Zhouqing, Zhao, Chongshun, Xue, Tao, Wu, Xin, Sun, Xiaoou, Wang, Zhong
Publicado no Drug Des Devel Ther (2018)

“... differences in safety outcomes were demonstrated. In subgroup analysis, 0.25 mg/kg dose of tenecteplase showed...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

28

Single dose pharmacokinetic equivalence study of two gabapentin preparations in healthy subjects

Single dose pharmacokinetic equivalence study of two gabapentin preparations in healthy subjects

Por Tjandrawinata, Raymond R, Setiawati, Effi, Putri, Ratih Sofia Ika, Yunaidi, Danang Agung, Amalia, Fawzia, Susanto, Liana W
Publicado em 2014

“... of the test drug or of the reference drug. Blood samples were drawn immediately before taking the drug...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

29

High-dose dexamethasone induced LPS-stimulated rat alveolar macrophages apoptosis

High-dose dexamethasone induced LPS-stimulated rat alveolar macrophages apoptosis

Por Zeng, Si, Qiao, Hui, Lv, Xue-wen, Fan, Dan, Liu, Tong, Xie, Dongli
Publicado no Drug Des Devel Ther (2017)

“...Prolonged administration of an excessive dose of corticosteroids proved to be harmful for patients...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

30

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator

Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator

Por Ong, Cheung-Ter, Wong, Yi-Sin, Wu, Chi-Shun, Su, Yu-Hsiang
Publicado no Drug Des Devel Ther (2017)

“...BACKGROUND AND PURPOSE: Intravenous recombinant tissue plasminogen activator (tPA) at a dose of 0.9...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

31

Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema

Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema

Por Hall, John
Publicado no Drug Des Devel Ther (2016)

Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

32

Current and emerging drugs for the treatment of inflammatory bowel disease

Current and emerging drugs for the treatment of inflammatory bowel disease

Por Triantafillidis, John K, Merikas, Emmanuel, Georgopoulos, Filippos
Publicado em 2011

“... mechanisms involved in the pathogenesis of IBD. However, conventional therapies remain the cornerstone...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

33

Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent postoperative nausea and vomiting after eye enucleation and orbital hydroxyapatite implant surgery: a randomized, double-blind trial

Higher dose of palonosetron versus lower dose of palonosetron plus droperidol to prevent...

Por Hu, Xiao, Tan, Fang, Gong, Lan
Publicado no Drug Des Devel Ther (2017)

“... to investigate the hypothesis that compared with monotherapy using a higher dose of palonosetron, using a lower...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

34

Pustular drug eruption due to Panax notoginseng saponins

Pustular drug eruption due to Panax notoginseng saponins

Por Yin, ZhiQiang, Ma, LiWen, Xu, JiaLi, Xia, JiPing, Luo, Dan
Publicado em 2014

“... counts, which required high-dose, long-term glucocorticoid therapy. To our knowledge, this is the first...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

35

Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses

Safety and pharmacokinetics of dicloxacillin in healthy Chinese volunteers following single and multiple oral doses

Por Wu, Guolan, Zheng, Yunliang, Zhou, Huili, Hu, Xingjiang, Liu, Jian, Zhai, You, Zhu, Meixiang, Wu, Lihua, Shentu, Jianzhong
Publicado no Drug Des Devel Ther (2015)

“... oral dose of 0.25–2.0 g dicloxacillin sodium, the maximum plasma drug concentration (C(max...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

36

Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability

Por Bandinelli, Francesca, Scazzariello, Francesco, Pimenta da Fonseca, Emanuela, Barreto Santiago, Mittermayer, Marcassa, Claudio, Nacci, Francesca, Matucci Cerinic, Marco
Publicado no Drug Des Devel Ther (2016)

“...-release prednisone taken in the morning. The efficacy of low-dose MR prednisolone in patients with SpA...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

37

Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil

Clinical features of hypophosphatemic osteomalacia induced by long-term low-dose adefovir dipivoxil

Por Zhu, Sheng, Yang, Yu-Hui, Gao, Rong-Wei, Li, Ran, Zou, Yu-Zhen, Feng, Lei, Zhang, Bo
Publicado no Drug Des Devel Ther (2017)

“..., as well as renal function, should be monitored for early detection of potential adverse drug reactions....”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

38

When is high-dose intravenous iron repletion needed? Assessing new treatment options

When is high-dose intravenous iron repletion needed? Assessing new treatment options

Por Gozzard, David
Publicado em 2011

“...High doses of intravenous iron have a role in the treatment of a number of clinical situations...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

39

Dose comparison of conivaptan (Vaprisol(®)) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics

Dose comparison of conivaptan (Vaprisol(®)) in patients with euvolemic or hypervolemic hyponatremia – efficacy, safety, and pharmacokinetics

Por Palmer, Biff F, Rock, Amy D, Woodward, Emily J
Publicado no Drug Des Devel Ther (2016)

“... days, following an initial 20 mg loading dose. Efficacy was evaluated by the magnitude and extent...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

40

Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation

Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation

Por Yu, Wei, Ji, Jinru, Xiao, Tingting, Ying, Chaoqun, Fang, Jiaheng, Shen, Ping, Xiao, Yonghong
Publicado no Drug Des Devel Ther (2017)

“... level of toxicity. The objective of this study was to obtain optimal dosing regimen of oral...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

[1]
Anterior
1
2
3
4
5
6
7
8
9
10
11
Seguinte
[31]